Redefining Co-Amorphous Solid Dispersions: The Role Of Flavonoids As Functional Carriers
Keywords:
Flavonoids, Co-Amorphous Solid Dispersion, Functional Carrier, Bioavailability, Therapeutic PotentialAbstract
The advancement of co-amorphous solid dispersions (CSDs) is reshaping drug formulation and tackling the difficulties with poorly soluble drugs. The flavonoids are emerging as innovative functional carriers within this realm. Flavonoids stand out as superior carriers in CSDs compared to traditional excipients, due to their natural, eco-friendly, non-toxicity, and better pharmacokinetic profile. They are also known for their antioxidant, anti-inflammatory, and bio-enhancing properties, and offer dual functionality by stabilizing amorphous drug forms and potentially enhancing bioavailability (BA). Thus, this review explores the potential of flavonoids to redefine CSDs, focusing on their role in improving drug stability, solubility, and BA through π-π stacking, hydrogen bonding, and electrostatic interactions. Such interactions between flavonoids and active pharmaceutical ingredients (APIs) contribute to the suppression of drug recrystallization, a key challenge in the long-term stability of amorphous formulations. This article also explains recent cell lines/ animal studies indicate that incorporating flavonoids as carriers in CSDs can enhance therapeutic outcomes, predominantly for poorly soluble drugs. The unique properties of flavonoids open new avenues in CSD design, making them promising candidates for future drug delivery systems.
Downloads
Metrics
References
Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Front Pharmacol. 2021 Feb 19;12:618411.
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007 Dec;12(23–24):1068–75.
Kaushik R, Budhwar V, Kaushik D. An Overview on Recent Patents and Technologies on Solid Dispersion. Recent Pat Drug Deliv Formul. 2020 Oct 13;14(1):63–74.
Singh A, Van Den Mooter G. Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev. 2016 May;100:27–50.
Baghel S, Cathcart H, O’Reilly NJ. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. J Pharm Sci. 2016 Sep;105(9):2527–44.
Liu J, Grohganz H, Löbmann K, Rades T, Hempel NJ. Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics. 2021 Mar 15;13(3):389.
Karagianni A, Kachrimanis K, Nikolakakis I. Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery. Pharmaceutics. 2018 Jul 19;10(3):98.
Xia Y, Xu R, Jiang C. The Research Progress on Cocrystals of Flavonoids. OALib. 2022;09(01):1–18.
Rode K, Maji I, Mahajan S, Singh PK. Unlocking the potential of flavonoid-based co-crystal and co-amorphous systems. Drug Discov Today. 2024 Jul;29(7):104050.
Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47.
Benet LZ, Broccatelli F, Oprea TI. BDDCS Applied to Over 900 Drugs. AAPS J. 2011 Dec;13(4):519–47.
Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, et al. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm Sin B. 2021 Aug;11(8):2505–36.
Boyd BJ, Bergström CAS, Vinarov Z, Kuentz M, Brouwers J, Augustijns P, et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci. 2019 Sep;137:104967.
Shah N, Sandhu H, Choi DS, Chokshi H, Malick AW, editors. Amorphous Solid Dispersions: Theory and Practice [Internet]. New York, NY: Springer New York; 2014 [cited 2024 Nov 10]. (Advances in Delivery Science and Technology). Available from: https://link.springer.com/10.1007/978-1-4939-1598-9
Luo C, Li R, Tang M, Gao Y, Zhang J, Qian S, et al. Amorphous solid dispersion to facilitate the delivery of poorly water-soluble drugs: recent advances on novel preparation processes and technology coupling. Expert Opin Drug Deliv. 2024 Nov 5;1–16.
Andrews GP, Qian K, Jacobs E, Jones DS, Tian Y. High drug loading nanosized amorphous solid dispersion (NASD) with enhanced in vitro solubility and permeability: Benchmarking conventional ASD. Int J Pharm. 2023 Feb;632:122551.
Tambe S, Jain D, Meruva SK, Rongala G, Juluri A, Nihalani G, et al. Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization. Pharmaceutics. 2022 Oct 16;14(10):2203.
Sonia Lombardo, Lucile Rametti-, Julien Leroudier, Hong Shen, Juliette Martin, Julien Boutet. How to Solve the Developability Challenges of Poorly Water Soluble New Chemical Entities for Oral Formulations. Am Pharm Rev. 2024;27(3):48–52.
Trasi NS, Bhujbal S, Zhou QT, Taylor LS. Amorphous solid dispersion formation via solvent granulation – A case study with ritonavir and lopinavir. Int J Pharm X. 2019 Dec;1:100035.
Pandi P, Bulusu R, Kommineni N, Khan W, Singh M. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020 Aug;586:119560.
Wu W, Ueda H, Löbmann K, Rades T, Grohganz H. Organic acids as co-formers for co-amorphous systems – Influence of variation in molar ratio on the physicochemical properties of the co-amorphous systems. Eur J Pharm Biopharm. 2018 Oct;131:25–32.
Nugrahani I, Jessica MA. Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review. Molecules. 2021 May 28;26(11):3279.
Löbmann K, Laitinen R, Grohganz H, Gordon KC, Strachan C, Rades T. Coamorphous Drug Systems: Enhanced Physical Stability and Dissolution Rate of Indomethacin and Naproxen. Mol Pharm. 2011 Oct 3;8(5):1919–28.
Gan Y, Baak JPA, Chen T, Ye H, Liao W, Lv H, et al. Supersaturation and Precipitation Applicated in Drug Delivery Systems: Development Strategies and Evaluation Approaches. Molecules. 2023 Feb 27;28(5):2212.
Shi Q, Moinuddin SM, Cai T. Advances in coamorphous drug delivery systems. Acta Pharm Sin B. 2019 Jan;9(1):19–35.
Budiman A, Rusdin A, Aulifa DL. Current Techniques of Water Solubility Improvement for Antioxidant Compounds and Their Correlation with Its Activity: Molecular Pharmaceutics. Antioxidants. 2023 Feb 4;12(2):378.
Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Amino acids as co-amorphous stabilizers for poorly water soluble drugs – Part 1: Preparation, stability and dissolution enhancement. Eur J Pharm Biopharm. 2013 Nov;85(3):873–81.
Jensen KT, Blaabjerg LI, Lenz E, Bohr A, Grohganz H, Kleinebudde P, et al. Preparation and characterization of spray-dried co-amorphous drug–amino acid salts. J Pharm Pharmacol. 2016 May 1;68(5):615–24.
Laitinen R, Löbmann K, Grohganz H, Strachan C, Rades T. Amino Acids as Co-amorphous Excipients for Simvastatin and Glibenclamide: Physical Properties and Stability. Mol Pharm. 2014 Jul 7;11(7):2381–9.
Korhonen O, Pajula K, Laitinen R. Rational excipient selection for co-amorphous formulations. Expert Opin Drug Deliv. 2017 Apr 3;14(4):551–69.
Löbmann K, Laitinen R, Grohganz H, Strachan C, Rades T, Gordon KC. A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin. Int J Pharm. 2013 Aug;453(1):80–7.
Russo MG, Sancho MI, Silva LMA, Baldoni HA, Venancio T, Ellena J, et al. Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Mar;156:70–7.
Gniado K, Löbmann K, Rades T, Erxleben A. The influence of co-formers on the dissolution rates of co-amorphous sulfamerazine/excipient systems. Int J Pharm. 2016 May;504(1–2):20–6.
Qi S, McAuley WJ, Yang Z, Tipduangta P. Physical Stabilization of Low-Molecular-Weight Amorphous Drugs in the Solid State: A Material Science Approach. Ther Deliv. 2014 Jul;5(7):817–41.
Chavan RB, Thipparaboina R, Kumar D, Shastri NR. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 2016;6(81):77569–76.
Huerta-Ochoa S, Castillo-Araiza CO, Guerrero AR, Prado-Barragán A. Whole-Cell Bioconversion of Citrus Flavonoids to Enhance Their Biological Properties. In: Studies in Natural Products Chemistry [Internet]. Elsevier; 2019 [cited 2024 Nov 6]. p. 335–67. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780444641830000099
Santos EL, Maia BHLNS, Ferriani AP, Teixeira SD. Flavonoids: Classification, Biosynthesis and Chemical Ecology. In: Justino GC, editor. Flavonoids - From Biosynthesis to Human Health [Internet]. InTech; 2017 [cited 2024 Nov 6]. Available from: http://www.intechopen.com/books/flavonoids-from-biosynthesis-to-human-health/flavonoids-classification-biosynthesis-and-chemical-ecology
Jaya Gupta, Amit Gupta and AK Gupta. Flavonoids: Its working mechanism and various protective roles. Int J Chem Stud. 2016;4(4):190–8.
Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, et al. Important Flavonoids and Their Role as a Therapeutic Agent. Molecules. 2020 Nov 11;25(22):5243.
Vullendula SKA, Nair AR, Yarlagadda DL, Navya Sree KS, Bhat K, Dengale SJ. Polymeric solid dispersion Vs co-amorphous technology: A critical comparison. J Drug Deliv Sci Technol. 2022 Dec;78:103980.
Rahmani A, Almatroudi A, Allemailem K, Alwanian W, Alharbi B, Alrumaihi F, et al. Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways. Int J Mol Sci. 2023 Jun 2;24(11):9665.
Hasan MdR, Islam MdN, Islam MdR. Phytochemistry, pharmacological activities and traditional uses of Emblica officinalis: A review. Int Curr Pharm J. 2016 Jan 18;5(2):14–21.
Ciumărnean L, Milaciu MV, Runcan O, Vesa Ștefan C, Răchișan AL, Negrean V, et al. The Effects of Flavonoids in Cardiovascular Diseases. Molecules. 2020 Sep 21;25(18):4320.
Orlikova B, Tasdemir D, Golais F, Dicato M, Diederich M. Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes Nutr. 2011 May;6(2):125–47.
Lee C, Hee Lim J, Young Cho A, Yoon W, Yun H, Won Kang J, et al. Molecular structures of flavonoid co-formers for cocrystallization with carbamazepine. J Ind Eng Chem. 2023 Feb;118:309–17.
Li J, Li M, Jiang H, Chen L, Zhang N, Zhou Y qi, et al. Selection of bionic Co-former improves the dissolution of Neohesperidin via Co-amorphous solid dispersion with Naringin. Eur J Pharm Biopharm. 2022 Dec;181:159–72.
Yarlagadda DL, Das S, Anand Vullendula SK, Manandhar S, Dengale SJ, Ranganath Pai KS, et al. Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement. Mol Pharm. 2024 Aug 5;21(8):3951–66.
Alhajj N, O’Reilly NJ, Cathcart H. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system. Int J Pharm. 2022 Apr;618:121657.
Wei Y, Zhou S, Hao T, Zhang J, Gao Y, Qian S. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin. Eur J Pharm Sci. 2019 Mar;129:21–30.
K. S. NS, Dengale SJ, Mutalik S, Bhat K. Raloxifene HCl – quercetin co-amorphous system: preparation, characterization, and investigation of its behavior in phosphate buffer. Drug Dev Ind Pharm. 2022 Jun 3;48(6):227–38.
Mallya P, Yarlagadda DL, Lewis S. A Novel Stability-Indicating RP-HPLC Method for the Simultaneous Estimation and In Vitro and In vivo Evaluation: Curcumin and Naringin Co-amorphous System. Food Anal Methods. 2024 May;17(5):751–65.
Garbiec E, Rosiak N, Zalewski P, Tajber L, Cielecka-Piontek J. Genistein Co-Amorphous Systems with Amino Acids: An Investigation into Enhanced Solubility and Biological Activity. Pharmaceutics. 2023 Nov 21;15(12):2653.
Zhao J, Yang J, Xie Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. Int J Pharm. 2019 Oct;570:118642.
Shi C, Guo C, Wang S, Li W, Zhang X, Lu S, et al. The mechanism of pectin in improving anthocyanin stability and the application progress of their complexes: A review. Food Chem X. 2024 Dec;24:101955.
Huang H, Zhang Y, Liu Y, Guo Y, Hu C. Influence of Intermolecular Interactions on Crystallite Size in Crystalline Solid Dispersions. Pharmaceutics. 2023 Oct 19;15(10):2493.
Zhang YN, Yin HM, Zhang Y, Zhang DJ, Su X, Kuang HX. Cocrystals of kaempferol, quercetin and myricetin with 4,4′-bipyridine: Crystal structures, analyses of intermolecular interactions and antibacterial properties. J Mol Struct. 2017 Feb;1130:199–207.
Su H, Lin HH, Su LJ, Lin CC, Jiang ZH, Chen SJ, et al. Direct immersion solid-phase microextraction combined with ambient ionization tandem mass spectrometry to rapidly distinguish pesticides in serum for emergency diagnostics. J Food Drug Anal. 2022 Mar 16;30(1):26–37.
Sims KR, He B, Koo H, Benoit DSW. Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin. ACS Omega. 2020 Jun 9;5(22):12649–59.
Liu K, Zha XQ, Li QM, Pan LH, Luo JP. Hydrophobic interaction and hydrogen bonding driving the self-assembling of quinoa protein and flavonoids. Food Hydrocoll. 2021 Sep;118:106807.
Zhang Y, Zhu B, Ji WJ, Guo CY, Hong M, Qi MH, et al. Insight into the Formation of Cocrystals of Flavonoids and 4,4′-Vinylenedipyridine: Heteromolecular Hydrogen Bonds, Molar Ratio, and Structural Analysis. Cryst Growth Des. 2021 May 5;21(5):2720–33.
Li X, Wang X, Liu H, Peng Y, Yan Y, Ni T. Mechanism evaluation of the interactions between eight flavonoids and γ-globulin based on multi-spectroscopy. J Mol Struct. 2021 Feb;1225:129291.
Sip S, Rosiak N, Sip A, Żarowski M, Hojan K, Cielecka-Piontek J. A Fisetin Delivery System for Neuroprotection: A Co-Amorphous Dispersion Prepared in Supercritical Carbon Dioxide. Antioxidants. 2023 Dec 21;13(1):24.
Garbiec E, Rosiak N, Zalewski P, Tajber L, Cielecka-Piontek J. Genistein Co-Amorphous Systems with Amino Acids: An Investigation into Enhanced Solubility and Biological Activity. Pharmaceutics. 2023 Nov 21;15(12):2653.
Hatwar P, Pathan IB, Chishti NAH, Ambekar W. Pellets containing quercetin amino acid co-amorphous mixture for the treatment of pain: Formulation, optimization, in-vitro and in-vivo study. J Drug Deliv Sci Technol. 2021 Apr;62:102350.
He H, Huang Y, Zhang Q, Wang JR, Mei X. Zwitterionic Cocrystals of Flavonoids and Proline: Solid-State Characterization, Pharmaceutical Properties, and Pharmacokinetic Performance. Cryst Growth Des. 2016 Apr 6;16(4):2348–56.
Vásquez-Reyes S, Bernal-Gámez M, Dominguez-Chavez J, Mondragón-Vásquez K, Sánchez-Tapia M, Ordaz G, et al. Effects of Novel Co-amorphous Naringenin and Fisetin Compounts on a Diet-induced Obesity Murine Model [Internet]. Medicine and Pharmacology; 2024 [cited 2024 Dec 8]. Available from: https://www.preprints.org/manuscript/202410.1627/v1
Mallya P, Yarlagadda DL, Lewis S. A Novel Stability-Indicating RP-HPLC Method for the Simultaneous Estimation and In Vitro and In vivo Evaluation: Curcumin and Naringin Co-amorphous System. Food Anal Methods. 2024 May;17(5):751–65.
Roy A, Khan A, Ahmad I, Alghamdi S, Rajab BS, Babalghith AO, et al. Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications. Ullah R, editor. BioMed Res Int. 2022 Jun 6;2022:1–9.
Salehi B, Cruz-Martins N, Butnariu M, Sarac I, Bagiu IC, Ezzat SM, et al. Hesperetin’s health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations. Crit Rev Food Sci Nutr. 2022 Jun 1;62(16):4449–64.
De Luna FCF, Ferreira WAS, Casseb SMM, De Oliveira EHC. Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin. Pharmaceuticals. 2023 Aug 30;16(9):1229.
Kobayashi M, Ikeda I. Mechanisms of Inhibition of Cholesterol Absorption by Green Tea Catechins. Food Sci Technol Res. 2017;23(5):627–36.
Sajid M, Channakesavula CN, Stone SR, Kaur P. Synthetic Biology towards Improved Flavonoid Pharmacokinetics. Biomolecules. 2021 May 18;11(5):754.
Abdel-Rahman A, Anyangwe N, Carlacci L, Casper S, Danam RP, Enongene E, et al. The Safety and Regulation of Natural Products Used as Foods and Food Ingredients. Toxicol Sci. 2011 Oct;123(2):333–48.
Balentine DA, Dwyer JT, Erdman JW, Ferruzzi MG, Gaine PC, Harnly JM, et al. Recommendations on reporting requirements for flavonoids in research. Am J Clin Nutr. 2015 Jun;101(6):1113–25.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
